TrueBlue (NYSE: TBI) director awarded 35,733 restricted stock units

Rhea-AI Filing Summary

TrueBlue, Inc. director Jeffrey B. Sakaguchi reported an equity award on Common Stock. He acquired 35,733 restricted stock units at a stated price of $0.00 per share, increasing his directly held stake to 124,443 shares after the transaction. The restricted stock units will be settled one-for-one in Common Stock and vest in full one year from the grant date.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SAKAGUCHI JEFFREY B

(Last) (First) (Middle)

1015 A STREET

(Street)

TACOMA WA 98402

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TrueBlue, Inc. [ TBI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/20/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/20/2026		A		35,733(1)	A	$0	124,443	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares acquired represent a grant of restricted stock units that will be settled for shares of Common Stock on a one-for-one basis in the future. The restricted stock units will vest in full one (1) year from the grant date.

Remarks:

	/s/ Todd N. Gilman, Attorney-in-fact	02/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did TrueBlue (TBI) disclose in this Form 4?

TrueBlue disclosed that director Jeffrey B. Sakaguchi acquired 35,733 restricted stock units of Common Stock as an equity award, which will convert into shares on a one-for-one basis after vesting in the future.

Was cash paid for the TrueBlue (TBI) shares reported in this Form 4?

No cash was paid for these shares. The Form 4 shows a grant of 35,733 restricted stock units at a transaction price of $0.00 per share, reflecting a stock-based compensation award rather than an open-market purchase.

When do Jeffrey B. Sakaguchi’s TrueBlue (TBI) restricted stock units vest?

The restricted stock units vest in full one year from the grant date. After vesting, they will be settled for shares of TrueBlue Common Stock on a one-for-one basis, according to the Form 4 footnote disclosure.

How many TrueBlue (TBI) shares does Jeffrey B. Sakaguchi hold after this Form 4 transaction?

Following the grant, Jeffrey B. Sakaguchi is reported as directly owning 124,443 shares of TrueBlue Common Stock. This total includes the impact of the newly awarded 35,733 restricted stock units reported in the Form 4.

Is the TrueBlue (TBI) Form 4 transaction a buy or a grant?

The transaction is a grant, not an open-market buy. It is classified with code "A" as a grant, award, or other acquisition of 35,733 restricted stock units, representing stock-based compensation to director Jeffrey B. Sakaguchi.